Low grade mosaicism in hereditary haemorrhagic telangiectasia identified by bidirectional whole genome sequencing reads through the 100,000 Genomes Project clinical diagnostic pipeline
| Autor: | Clarke, J, Alikian, M, Xiao, S, Kasperaviciute, D, Thomas, E, Turbin, I, Rose, G, Olupona, K, Cifra, E, Curetean, E, Ferguson, T, Redhead, J, Genomics England Research Consortium, Shovlin, C |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty 030105 genetics & heredity Biology Genome DNA sequencing 03 medical and health sciences Molecular genetics Genetics medicine Humans Pathology Molecular Gene 11 Medical and Health Sciences Genetics (clinical) Genetics & Heredity Whole genome sequencing Whole Genome Sequencing Mosaicism Endoglin Autosomal dominant trait Genetic Variation Membrane Proteins ACVRL1 Heterozygote advantage 06 Biological Sciences Middle Aged 030104 developmental biology Genomics England Research Consortium molecular genetics Female Telangiectasia Hereditary Hemorrhagic Genome-Wide Studies |
| Zdroj: | Journal of Medical Genetics |
| ISSN: | 1468-6244 0022-2593 |
| Popis: | Whole-genome sequencing (WGS) has been championed within the UK National Health Service (NHS) and represents one of the approaches within the forthcoming UK National Genomic Test Directory to identify genetic variants that cause particular rare inherited diseases.1 Although diploid organisms such as man develop from a single cell, postzygotic somatic mutations occur and lead to mosaicism.2 Sufficiently early generation of a disease-causing DNA sequence variant can result in a mosaic individual who is the first member of a family to be affected by an inherited disorder.3 4 Their causative DNA sequence variant is likely to be present at less than the 50% expected for a heterozygote, and may be difficult to detect with confidence. Greater ability to detect mosaicism has been used to favour higher depth panel-based sequencing rather than WGS as, due to sequencing capacities, there are trade-offs between the number of target nucleotides sequenced and the average depth of reads at any given nucleotide. It is increasingly recognised that hereditary haemorrhagic telangiectasia (HHT5) is a condition where the first affected member of the family may be a mosaic.3 4 HHT is transmitted as an autosomal dominant trait via a single pathogenic DNA sequence variant, usually in ENG , ACVRL1 or SMAD4 .5 There are hundreds of different pathogenic variants in these genes in different HHT families, all resulting in similar clinical features.6 HHT is diagnosed clinically by the presence of at least three Curacao Criteria: recurrent nosebleeds, mucocutaneous telangiectasia, visceral involvement such as pulmonary, hepatic, gastrointestinal or cerebral arteriovenous malformations (AVMs), and an affected first-degree relative.5 A high index of suspicion for HHT is warranted, particularly in cases where more than one AVM is present or where multiple generations display these features. As we have shown, however, high proportions of … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|